Mankind Pharma Limited (NSE:MANKIND)
India flag India · Delayed Price · Currency is INR
2,638.60
-21.40 (-0.80%)
Nov 12, 2026, 3:29 PM IST

Mankind Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
1,089,861828,0511,000,400921,654--
Market Cap Growth
18.91%-17.23%8.54%---
Enterprise Value
1,120,206879,179960,198902,241--
Last Close Price
2660.002005.802423.792299.84--

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
48.6443.2950.2548.18--
Forward PE
40.7235.5345.1343.88--
PS Ratio
7.085.808.208.98--
PB Ratio
6.105.006.879.63--
P/TBV Ratio
61.66497.03-12.00--
P/FCF Ratio
42.8833.1851.2450.17--
P/OCF Ratio
32.9626.5341.4542.82--
PEG Ratio
1.962.142.641.91--

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
7.286.167.878.79--
EV/EBITDA Ratio
27.0924.2231.0735.87--
EV/EBIT Ratio
34.2131.1938.2841.96--
EV/FCF Ratio
44.0735.2349.1849.11--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.300.380.580.020.020.14
Debt / EBITDA Ratio
1.321.732.740.080.090.44
Debt / FCF Ratio
2.132.534.360.110.171.94
Net Debt / Equity Ratio
0.160.250.41-0.33-0.18-0.06
Net Debt / EBITDA Ratio
0.681.131.95-1.26-0.71-0.20
Net Debt / FCF Ratio
1.091.653.08-1.73-1.32-0.87
Asset Turnover
0.530.510.620.950.931.00
Inventory Turnover
2.062.012.012.171.841.69
Quick Ratio
0.820.610.722.021.140.65
Current Ratio
1.351.071.233.102.321.68
Return on Equity (ROE)
13.56%12.45%16.62%22.57%18.79%25.99%
Return on Assets (ROA)
7.05%6.31%7.89%12.40%10.53%14.76%
Return on Invested Capital (ROIC)
12.46%11.36%14.83%27.47%20.42%29.77%
Return on Capital Employed (ROCE)
14.10%13.10%11.40%21.80%20.20%28.10%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
2.06%2.31%1.99%2.08%--
FCF Yield
2.33%3.01%1.95%1.99%--
Payout Ratio
-2.16%----
Buyback Yield / Dilution
-0.67%-2.13%-0.88%-0.14%-0.00%-
Total Shareholder Return
-0.59%-2.13%-0.88%-0.14%-0.00%-